• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

坦索罗辛在全身麻醉期间引起严重低血压:一例病例报告。

Tamsulosin-induced severe hypotension during general anesthesia: a case report.

作者信息

Kumar Dileep, Khan Fauzia Anis

机构信息

Department of Anesthesia, Aga Khan University PO Box 3500, Stadium Road, Karachi, Pakistan.

出版信息

J Med Case Rep. 2010 Nov 17;4:365. doi: 10.1186/1752-1947-4-365.

DOI:10.1186/1752-1947-4-365
PMID:21083875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3000845/
Abstract

INTRODUCTION

Tamsulosin, a selective α1-adrenergic receptor (α1-AR) antagonist, is a widely prescribed first-line agent for benign prostatic hypertrophy (BPH). Its interaction with anesthetic agents has not been described.

CASE PRESENTATION

We report the case of 54-year-old Asian man undergoing elective left thyroid lobectomy. The only medication the patient was taking was tamsulosin 0.4 mg for the past year for BPH. He developed persistent hypotension during the maintenance phase of anesthesia while receiving oxygen, nitrous oxide and 1% isoflurane. The hypotension could have been attributable to a possible interaction between inhalational anesthetic and tamsulosin.

CONCLUSION

Vigilance for unexpected hypotension is important in surgical patients who are treated with selective α1-AR blockers. If hypotension occurs, vasopressors that act directly on adrenergic receptors could be more effective.

摘要

引言

坦索罗辛是一种选择性α1肾上腺素能受体(α1-AR)拮抗剂,是治疗良性前列腺增生(BPH)广泛使用的一线药物。其与麻醉剂的相互作用尚未见报道。

病例报告

我们报告一例54岁亚洲男性接受择期左甲状腺叶切除术。该患者过去一年仅服用坦索罗辛0.4mg治疗BPH。在麻醉维持期,当给予氧气、氧化亚氮和1%异氟烷时,他出现了持续性低血压。低血压可能归因于吸入性麻醉剂与坦索罗辛之间可能的相互作用。

结论

对于接受选择性α1-AR阻滞剂治疗的手术患者,警惕意外低血压很重要。如果发生低血压,直接作用于肾上腺素能受体的血管升压药可能更有效。

相似文献

1
Tamsulosin-induced severe hypotension during general anesthesia: a case report.坦索罗辛在全身麻醉期间引起严重低血压:一例病例报告。
J Med Case Rep. 2010 Nov 17;4:365. doi: 10.1186/1752-1947-4-365.
2
Revisiting the Pharmacodynamic Uroselectivity of -Adrenergic Receptor Antagonists.重新探讨 -肾上腺素能受体拮抗剂的药效学尿选择性。
J Pharmacol Exp Ther. 2019 Oct;371(1):106-112. doi: 10.1124/jpet.119.260216. Epub 2019 Jul 8.
3
Tamsulosin-induced life-threatening hypotension in a patient with spinal cord injury: A case report.坦索罗辛致脊髓损伤患者危及生命的低血压:一例报告
World J Clin Cases. 2022 Sep 6;10(25):9142-9147. doi: 10.12998/wjcc.v10.i25.9142.
4
Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms.坦索罗辛:其药理学及治疗下尿路症状疗效的综述
Drugs Aging. 2002;19(2):135-61. doi: 10.2165/00002512-200219020-00004.
5
Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia.坦索罗辛与老年良性前列腺增生男性患痴呆症的风险
Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):340-348. doi: 10.1002/pds.4361. Epub 2018 Jan 9.
6
Comparison of relaxation responses of cavernous and trigonal smooth muscles from rabbits by alpha1-adrenoceptor antagonists; prazosin, terazosin, doxazosin, and tamsulosin.α1肾上腺素能受体拮抗剂(哌唑嗪、特拉唑嗪、多沙唑嗪和坦索罗辛)对兔海绵体和平滑肌舒张反应的比较。
J Korean Med Sci. 1999 Feb;14(1):69-74. doi: 10.3346/jkms.1999.14.1.69.
7
Reversible exacerbation of obstructive sleep apnea by α1-adrenergic blockade with tamsulosin: A case report.坦索罗辛α1-肾上腺素能阻滞致阻塞性睡眠呼吸暂停可逆性加重:一例报告
Respir Med Case Rep. 2016 Oct 14;19:181-186. doi: 10.1016/j.rmcr.2016.10.005. eCollection 2016.
8
Severe hypotension in a patient receiving pemoline during general anesthesia.
Anesth Analg. 2000 Nov;91(5):1131-3. doi: 10.1097/00000539-200011000-00015.
9
Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.两种α1肾上腺素能受体拮抗剂萘哌地尔和盐酸坦索罗辛治疗良性前列腺增生所致下尿路症状的比较:一项随机交叉研究。
BJU Int. 2006 Apr;97(4):747-51, discussion 751. doi: 10.1111/j.1464-410X.2006.06030.x.
10
Subtype selective alpha1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia.用于治疗良性前列腺增生的亚型选择性α1-肾上腺素能受体拮抗剂。
Expert Opin Investig Drugs. 1999 Dec;8(12):2073-2094. doi: 10.1517/13543784.8.12.2073.

引用本文的文献

1
Tamsulosin-induced life-threatening hypotension in a patient with spinal cord injury: A case report.坦索罗辛致脊髓损伤患者危及生命的低血压:一例报告
World J Clin Cases. 2022 Sep 6;10(25):9142-9147. doi: 10.12998/wjcc.v10.i25.9142.
2
Severe hypotension during general anesthesia in a patient on chronic high-dose Tamsulosin therapy.一名长期接受高剂量坦索罗辛治疗的患者在全身麻醉期间发生严重低血压。
Anesth Essays Res. 2013 May-Aug;7(2):285-6. doi: 10.4103/0259-1162.118985.

本文引用的文献

1
A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia.α-肾上腺素能阻滞剂治疗良性前列腺增生相关症状的血管相关安全性和疗效的荟萃分析。
Int J Clin Pract. 2008 Oct;62(10):1547-59. doi: 10.1111/j.1742-1241.2008.01880.x.
2
A 6-month large-scale study into the safety of tamsulosin.一项为期6个月的坦索罗辛安全性大规模研究。
Br J Clin Pharmacol. 2001 Jun;51(6):609-14. doi: 10.1046/j.0306-5251.2001.01388.x.
3
A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing.特拉唑嗪与坦索罗辛对动态血压及夜间直立位应激试验的不同影响的双盲比较。
Eur Urol. 1998;33(5):481-8. doi: 10.1159/000019639.
4
Alpha-blockade therapy for benign prostatic hyperplasia: from a nonselective to a more selective alpha1A-adrenergic antagonist.
Urology. 1998 Jun;51(6):861-72. doi: 10.1016/s0090-4295(98)00140-x.
5
Coadministration of tamsulosin and three antihypertensive agents in patients with benign prostatic hyperplasia: pharmacodynamic effect.坦索罗辛与三种抗高血压药物联合应用于良性前列腺增生患者:药效学作用。
Clin Ther. 1997 Jul-Aug;19(4):730-42. doi: 10.1016/s0149-2918(97)80097-5.
6
Tamsulosin. A review of its pharmacological properties and therapeutic potential in the management of symptomatic benign prostatic hyperplasia.
Drugs. 1996 Dec;52(6):883-98. doi: 10.2165/00003495-199652060-00012.
7
The prevalence of prostatism: a population-based survey of urinary symptoms.
J Urol. 1993 Jul;150(1):85-9. doi: 10.1016/s0022-5347(17)35405-8.
8
Use of recombinant alpha 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy.
Eur J Pharmacol. 1995 Jan 16;288(2):201-7. doi: 10.1016/0922-4106(95)90195-7.
9
The development of human benign prostatic hyperplasia with age.人类良性前列腺增生随年龄的发展。
J Urol. 1984 Sep;132(3):474-9. doi: 10.1016/s0022-5347(17)49698-4.